Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Deep Track Biotechnology Master Fund Ltd | 10% Owner | 2025-08-22 | 970,143 | $10.59 | $10.27MSell |
Scott Dunseth Myers | Director | 2025-08-22 | 3,800 | $10.82 | $41.12kBuy |
Deep Track Biotechnology Master Fund Ltd | 10% Owner | 2025-08-21 | 1,094,994 | $11.03 | $12.08MSell |
David F. Novack | President COO | 2025-03-24 | 10,000 | $14.00 | $140.00kSell |
David F. Novack | President COO | 2025-03-24 | 10,000 | $6.81 | $68.05kBuy |
David F. Novack | President COO | 2025-03-18 | 14,020 | $13.58 | $190.39kSell |
David F. Novack | President COO | 2025-03-07 | 32,764 | $14.39 | $471.47kSell |
John L. Slebir | SVP General Counsel | 2025-02-18 | 5,358 | $12.93 | $69.28kSell |
Ryan Spencer | CEO and Director | 2025-02-18 | 36,528 | $12.93 | $472.31kSell |
Robert Janssen | SVP and CMO | 2025-02-18 | 4,041 | $12.93 | $52.25kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Bvf Partners L P | 21.01% | 25,226,061 | $241.41M | Insider |
Deep Track Capital LP | 14.82% | 17,791,486 | $170.26M | Institution |
Blackrock Inc | 14.36% | 17,246,496 | $165.05M | Institution |
Deep Track Biotechnology Master Fund Ltd | 13.10% | 15,726,349 | $150.50M | Insider |
Symphony Capital Partners LP | 7.52% | 9,031,431 | $86.43M | Insider |
Vanguard Group Inc | 7.02% | 8,426,954 | $80.65M | Institution |
James E. Flynn | 6.65% | 7,982,041 | $76.39M | Insider |
State Street Corp | 5.33% | 6,395,949 | $61.21M | Institution |
Chicago Capital LLC | 4.35% | 5,227,909 | $50.03M | Institution |
Dimensional Fund Advisors LP | 3.04% | 3,644,479 | $34.88M | Institution |